Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 13/20 | 0.70 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.57 |
| ▸ | TTPA | P49638 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.57 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.56 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23166794 | 1.00 | ALOX5 (0.70) | ALOX5MAPTLMNAMEN1GSTP1 | |
| SCHEMBL29670818 | 1.00 | ALOX5 (0.70) | ALOX5MAPTLMNAMEN1GSTP1 | |
| SCHEMBL31369406 | 1.00 | ALOX5 (0.70) | ALOX5MAPTLMNAMEN1GSTP1 | |
| SCHEMBL23166879 | 1.00 | ALOX5 (0.70) | ALOX5MAPTLMNAMEN1GSTP1 | |
| SCHEMBL29670814 | 1.00 | ALOX5 (0.70) | ALOX5MAPTLMNAMEN1GSTP1 | |
| SCHEMBL23166910 | 0.93 | ALOX5 (0.82) | ALOX5MAPT | |
| SCHEMBL23167044 | 0.93 | ALOX5 (0.82) | ALOX5MAPT | |
| Alpha-Tocotrienol SCHEMBL2364445 | 0.93 | ALOX5 (0.82) | ALOX5MAPT | |
| Alpha-Tocotrienol SCHEMBL31053049 | 0.93 | ALOX5 (0.82) | ALOX5MAPT | |
| SCHEMBL23166911 | 0.93 | ALOX5 (0.82) | ALOX5MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240368098-A1 | COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF MITOCHONDRIAL DISEASE, INCLUDING FRIEDREICH'S ATAXIA | STEALTH BIOTHERAPEUTICS INC. (US) | 2024-11-07 | — | — | US | disclosed |
| US-20240293339-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF VARIOUS MITOCHONDRIAL DISEASES OR DISORDERS, INCLUDING FRIEDREICH'S ATAXIA | Stealth Bio Therapeutics Inc. (US) | 2024-09-05 | — | — | US | disclosed |
| US-12049455-B2 | Compositions and methods for the prevention and/or treatment of mitochondrial disease, including Friedreich's ataxia | STEALTH BIOTHERAPEUTICS INC. (US) | 2024-07-30 | — | — | US | disclosed |
| EP-4351547-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF VARIOUS MITOCHONDRIAL DISEASES OR DISORDERS, INCLUDING FRIEDREICH'S ATAXIA | Stealth BioTherapeutics Inc. (US) | 2024-04-17 | — | — | EP | disclosed |
| US-20230303506-A1 | COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF MITOCHONDRIAL DISEASE, INCLUDING FRIEDREICH'S ATAXIA | STEALTH BIOTHERAPEUTICS INC. (US) | 2023-09-28 | — | — | US | disclosed |
| US-11584728-B2 | Compositions and methods for the prevention and/or treatment of mitochondrial disease, including Friedreich's ataxia | STEALTH BIOTHERAPEUTICS INC. (US) | 2023-02-21 | — | — | US | disclosed |
| WO-2022261347-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF VARIOUS MITOCHONDRIAL DISEASES OR DISORDERS, INCLUDING FRIEDREICH'S ATAXIA | STEALTH BIOTHERAPEUTICS INC. (US) | 2022-12-15 | — | — | WO | disclosed |
| EP-4038076-A1 | CHINONE-, HYDROCHINOME- AND NAPHTHOCHINONE-ANALOGUES OF VATIQUIONE FOR TREATMENT OF MITOCHONDRIAL DISORDER DISEASES | Stealth BioTherapeutics Inc. (US) | 2022-08-10 | — | — | EP | disclosed |
| CN-114746430-A | Quinone-, hydroquinone-and naphthoquinone-analogues of vattinoquinone for the treatment of mitochondrial disorders | 康德生物医疗有限公司 | 2022-07-12 | — | — | CN | disclosed |
| US-20210206736-A1 | COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF MITOCHONDRIAL DISEASE, INCLUDING FRIEDREICH'S ATAXIA | STEALTH BIOTHERAPEUTICS INC. | 2021-07-08 | — | — | US | disclosed |
| WO-2021067836-A1 | CHINONE-, HYDROCHINOME- AND NAPHTHOCHINONE-ANALOGUES OF VATIQUIONE FOR TREATMENT OF MITOCHONDRIAL DISORDER DISEASES | STEALTH BIOTHERAPEUTICS CORP (MC) | 2021-04-08 | — | — | WO | disclosed |
| US-8106223-B2 | Process for the production of alpha-tocotrienol and derivatives | EDISON PHARMACEUTICALS, INC. (US) | 2012-01-31 | — | — | US | disclosed |
| US-20100105930-A1 | PROCESS FOR THE PRODUCTION OF ALPHA-TOCOTRIENOL AND DERIVATIVES | PTC THERAPEUTICS, INC. | 2010-04-29 | — | — | US | disclosed |
| US-6465548-B1 | 6-HYDROXYCHROMAN DERIVATIVE WITH PHOSPHORUS AND PHENOLIC ANTIOXIDANTS; HEAT, LIGHT AND OXIDATION STABILITY DURING MOLDING | YOSHITOMI FINE CHEMICALS, LTD. (JP) | 2002-10-15 | — | — | US | disclosed |
| EP-0414106-B1 | Process for the preparation of terpenes | EISAI CO LTD (JP) | 1996-03-27 | — | — | EP | disclosed |
| US-5073659-A | Alkylation, Grignard reagent, zinc chloride catalyst and coppe r compound | EISAI CO., LTD. (JP) | 1991-12-17 | — | — | US | disclosed |
| US-4634778-A | Process for preparing chlorinated ethylenic derivatives | RHONE-POULENC SANTE (FR) | 1987-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240293339-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF VARIOUS MITOCHONDRIAL DISEASES OR DISORDERS, INCLUDING FRIEDREICH'S ATAXIA | AIFM2, FH, FECH | ALOX5 288/4885MAPT 322/4885LMNA 528/4885 |
| US-20230303506-A1 | COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF MITOCHONDRIAL DISEASE, INCLUDING FRIEDREICH'S ATAXIA | FH, COQ8A, TFAM | ALOX5 1622/4885MAPT 1057/4885LMNA 1541/4885 |
| US-11584728-B2 | Compositions and methods for the prevention and/or treatment of mitochondrial disease, including Friedreich's ataxia | FH, COQ8A, TFAM | ALOX5 1622/4885MAPT 1057/4885LMNA 1541/4885 |
| US-20210206736-A1 | COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF MITOCHONDRIAL DISEASE, INCLUDING FRIEDREICH'S ATAXIA | FH, COQ8A, TFAM | ALOX5 1622/4885MAPT 1057/4885LMNA 1541/4885 |
| US-12049455-B2 | Compositions and methods for the prevention and/or treatment of mitochondrial disease, including Friedreich's ataxia | FH, COQ8A, TFAM | ALOX5 1622/4885MAPT 1057/4885LMNA 1541/4885 |
| US-20240368098-A1 | COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF MITOCHONDRIAL DISEASE, INCLUDING FRIEDREICH'S ATAXIA | FH, COQ8A, TFAM | ALOX5 1622/4885MAPT 1057/4885LMNA 1541/4885 |
| US-20100105930-A1 | PROCESS FOR THE PRODUCTION OF ALPHA-TOCOTRIENOL AND DERIVATIVES | TTPA, LCAT, PCTP | ALOX5 76/4885MAPT 2318/4885LMNA 2953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.